Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R. & Fletcher, A. A. Pancreatic extracts in the treatment of diabetes mellitus. Can. Med. Assoc. J. 12, 141–146 (1922).CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
The History of a Wonderful Thing We Call Insulin. American Diabetes Association https://www.diabetes.org/blog/history-wonderful-thing-we-call-insulin (2019).Facts & figures. International Diabetes Federation https://idf.org/about-diabetes/diabetes-facts-figures/ (2023).Brange, J., Langkj\sgmaelig;r, L., Havelund, S. & Vølund, A. Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations. Pharm. Res. 9, 715–726 (1992).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Brange, J., Havelund, S. & Hougaard, P. Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations. Pharm. Res. J. Am. Assoc. Pharm. Sci. 9, 727–734 (1992).CASÂ
Google ScholarÂ
Weiss, M. Insulin analogues containing penta-fluoro-phenylalanine at position B24. US patent US 9200053 B2 (2015).Groenning, M., Frokjaer, S. & Vestergaard, B. Formation mechanism of insulin fibrils and structural aspects of the insulin fibrillation process. Curr. Protein Pept. Sci. 10, 509–528 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Nielsen, L. et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40, 6036–6046 (2001).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Oliva, A., Fariña, J. B. & Llabrés, M. Influence of temperature and shaking on stability of insulin preparations: degradation kinetics. Int. J. Pharm. 143, 163–170 (1996).ArticleÂ
CASÂ
Google ScholarÂ
Nakamura, M. et al. Extreme adhesion activity of amyloid fibrils induces subcutaneous insulin resistance. Diabetes 68, 609–616 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Nilsson, M. R. Insulin amyloid at injection sites of patients with diabetes. Amyloid 23, 139–147 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Selkoe, D. J. Folding proteins in fatal ways. Nature 426, 900–904 (2003).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gong, H. et al. Effects of several quinones on insulin aggregation. Sci. Rep. 4, 5648–5656 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Levy-Sakin, M., Shreberk, M., Daniel, Y. & Gazit, E. Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors. Islets 1, 210–215 (2009).ArticleÂ
PubMedÂ
Google ScholarÂ
Ivanova, M. I., Sievers, S. A., Sawaya, M. R., Wall, J. S. & Eisenberg, D. Molecular basis for insulin fibril assembly. Proc. Natl Acad. Sci. USA 106, 18990–18995 (2009).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Chowdhury, S. R., Mondal, S. & Iyer, P. K. Blocking oligomeric insulin amyloid fibrillation via perylenebisimides containing dipeptide tentacles. ACS Biomater. Sci. Eng. 4, 4076–4083 (2018).ArticleÂ
Google ScholarÂ
Mishra, N. K., Joshi, K. B. & Verma, S. Inhibition of human and bovine insulin fibril formation by designed peptide conjugates. Mol. Pharm. 10, 3903–3912 (2013).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Mishra, N. K., Krishna Deepak, R. N. V., Sankararamakrishnan, R. & Verma, S. Controlling in vitro insulin amyloidosis with stable peptide conjugates: a combined experimental and computational study. J. Phys. Chem. B 119, 15395–15406 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Sen, S. et al. Blended polar/nonpolar peptide conjugate interferes with human insulin amyloid-mediated cytotoxicity. Bioorg. Chem. 111, 104899 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Skaat, H., Belfort, G. & Margel, S. Synthesis and characterization of fluorinated magnetic core-shell nanoparticles for inhibition of insulinamyloid fibril formation. Nanotechnology 20, 225106 (2009).ArticleÂ
PubMedÂ
Google ScholarÂ
Vilasi, S., Iannuzzi, C., Portaccio, M., Irace, G. & Sirangelo, I. Effect of trehalose on W7FW14F apomyoglobin and insulin fibrillization: new insight into inhibition activity. Biochemistry 47, 1789–1796 (2008).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Mari, E. et al. Trehalose effect on the aggregation of model proteins into amyloid fibrils. Life 10, 60 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, S. H., Dong, X. Y. & Sun, Y. Effect of (-)-epigallocatechin-3-gallate on human insulin fibrillation/aggregation kinetics. Biochem. Eng. J. 63, 38–49 (2012).ArticleÂ
CASÂ
Google ScholarÂ
Mukherjee, M., Jana, J. & Chatterjee, S. A small molecule impedes insulin fibrillation: another new role of phenothiazine derivatives. ChemistryOpen 7, 68–79 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chernii, S. et al. Study of tetraphenylporphyrins as modifiers of insulin amyloid aggregation. J. Mol. Recognit. 33, e2811 (2019).ArticleÂ
PubMedÂ
Google ScholarÂ
Kovalska, V. et al. The impact of binding of macrocyclic metal complexes on amyloid fibrillization of insulin and lysozyme. J. Mol. Recognit. 30, e2622 (2017).ArticleÂ
Google ScholarÂ
Mauri, S., Volk, M., Byard, S., Berchtold, H. & Arnolds, H. Stabilization of insulin by adsorption on a hydrophobic silane self- assembled monolayer. Langmuir 31, 8892–8900 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Weber, C., Kammerer, D., Streit, B. & Licht, A. H. Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release. Toxicol. Rep. 2, 194–202 (2015).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wheeler, B. J. & Taylor, B. J. Successful management of allergy to the insulin excipient metacresol in a child with type 1 diabetes: a case report. J. Med. Case Rep. 6, 263 (2012).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Rege, N. K. et al. Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic–aromatic interactions. J. Biol. Chem. 293, 10895–10910 (2018).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pandyarajan, V. et al. Contribution of tyrb26to the function and stability of insulin structure-activity relationships at a conserved hormone-receptor interface. J. Biol. Chem. 291, 12978–12990 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Lieblich, S. A. et al. 4S-hydroxylation of insulin at ProB28 accelerates hexamer dissociation and delays fibrillation. J. Am. Chem. Soc. 139, 8384–8387 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pandyarajan, V. et al. Biophysical optimization of a therapeutic protein by nonstandard mutagenesis: studies of an iodo-insulin derivative. J. Biol. Chem. 289, 23367–23381 (2014).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Weiss, M. Halogen-stabilized insulin. US patent US8921313B2 (2014).Vinther, T. N. et al. Additional disulfide bonds in insulin: prediction, recombinant expression, receptor binding affinity, and stability. Protein Sci. 24, 779–788 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Karas, J. A. et al. Total chemical synthesis of an intra-a-chain cystathionine human insulin analogue with enhanced thermal stability. Angew. Chem. Int. Ed. 55, 14743–14747 (2016).ArticleÂ
CASÂ
Google ScholarÂ
Mao, R., Chen, Y., Chi, Z. & Wang, Y. Insulin and its single-chain analogue. Appl. Microbiol. Biotechnol. 103, 8737–8751 (2019). at.ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hua, Q. X. et al. Design of an active ultrastable single-chain insulin analog: synthesis, structure, and therapeutic implications. J. Biol. Chem. 283, 14703–14716 (2008).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Glidden, M. D. et al. An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein. J. Biol. Chem. 293, 47–68 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kjeldsen, T., Schlein, M., Sorenson, A. R. & Madsen, P. Single-chain insulin. US patent US8883449B2 (2014).Hossain, M. A. et al. Total chemical synthesis of a nonfibrillating human glycoinsulin. J. Am. Chem. Soc. 142, 1164–1169 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Xiong, X. et al. Novel four-disulfide insulin analog with high aggregation stability and potency. Chem. Sci. 11, 195–200 (2020).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Chen, H. et al. Selective lysine modification of native peptides via aza-Michael addition. Org. Biomol. Chem. 15, 7339–7345 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Boga, S. B. et al. Site-selective synthesis of insulin azides and bioconjugates. Bioconjug. Chem. 30, 1127–1132 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kamelnia, R. et al. Chemical modification of the amino groups of human insulin: investigating structural properties and amorphous aggregation of acetylated species. Protein J. 42, 383–398 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zaykov, A. N., Mayer, J. P. & Dimarchi, R. D. Pursuit of a perfect insulin. Nat. Rev. Drug Discov. 15, 425–439 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Rege, N. K. et al. Evolution of insulin at the edge of foldability and its medical implications. Proc. Natl Acad. Sci. USA 117, 29618–29628 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Yang, C., Lu, D. & Liu, Z. How PEGylation enhances the stability and potency of insulin: a molecular dynamics simulation. Biochemistry 50, 2585–2593 (2011).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jia, Y., Fernandez, A. & Sampath, J. PEGylation of insulin and lysozyme to stabilize against thermal denaturation: a molecular dynamics simulation study. J. Phys. Chem. B 127, 6856–6866 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hinds, K. et al. Synthesis and characterization of poly(ethylene glycol)-insulin conjugates. Bioconjug. Chem. 11, 195–201 (2000).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Rasmussen, T., Kasimova, M. R., Jiskoot, W. & van de Weert, M. The chaperone-like protein α-crystallin dissociates insulin dimers and hexamers. Biochemistry 48, 9313–9320 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Huus, K., Havelund, S., Olsen, H. B., Van De Weert, M. & Frokjaer, S. Thermal dissociation and unfolding of insulin. Biochemistry 44, 11171–11177 (2005).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yang, J. et al. Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from wistar-kyoto rats. Am. J. Hypertens. 22, 770–776 (2009).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Purushottam, L. et al. Single-site glycine-specific labeling of proteins. Nat. Commun. 10, 1–9 (2019).ArticleÂ
CASÂ
Google ScholarÂ
Cohen, P. The twentieth century struggle to decipher insulin signalling. Nat. Rev. Mol. Cell Biol. 7, 867–873 (2006).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Alfa, R. W. & Kim, S. K. Using Drosophila to discover mechanisms underlying type 2 diabetes. DMM. Dis. Model. Mech. 9, 365–376 (2016).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Graham, P. & Pick, L. Drosophila as a model for diabetes and diseases of insulin resistance. Curr. Top. Dev. Biol. 121, 397–419 (2017).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Goberdhan, D. C. I. & Wilson, C. The functions of insulin signaling: size isn’t everything, even in Drosophila. Differentiation 71, 375–397 (2003).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Hirabayashi, S., Baranski, T. J. & Cagan, R. L. Transformed drosophila cells evade diet-mediated insulin resistance through wingless signaling. Cell 154, 664–675 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Brogiolo, W. et al. An evolutionarily conserved function of the drosophila insulin receptor and insulin-like peptides in growth control. Curr. Biol. 11, 213–221 (2001).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Tatar, M. et al. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107–110 (2001).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Britton, J. S., Lockwood, W. K., Li, L., Cohen, S. M. & Edgar, B. A. Drosophila’s insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions. Dev. Cell 2, 239–249 (2002).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Gray, A., Van Der Kaay, J. & Downes, C. P. The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate. Biochem. J. 344, 929–936 (1999).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Like, A. A. & Rossini, A. A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417 (1976).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Heinemann, L., Braune, K., Carter, A., Zayani, A. & Krämer, L. A. Insulin storage: a critical reappraisal. J. Diabetes Sci. Technol. 15, 147–159 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kjeldsen, T. B. et al. Engineering of orally available, ultralong-acting insulin analogues: discovery of OI338 and OI320. J. Med. Chem. 64, 616–628 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Kjeldsen, T. B. et al. Molecular engineering of insulin icodec, the first acylated insulin analog for once-weekly administration in humans. J. Med. Chem. 64, 8942–8950 (2021).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jonassen, I. et al. Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharm. Res. 29, 2104–2114 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bocian, W. et al. Structure of human insulin monomer in water/acetonitrile solution. J. Biomol. NMR 40, 55–64 (2008).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Anandakrishnan, R., Aguilar, B. & Onufriev, A. V. H. ++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res. 40, W537–W541 (2012).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696–3713 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).ArticleÂ
CASÂ
Google ScholarÂ
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157–1174 (2004).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ